IP Verse

Compositions Comprising Amlodipine And Bisoprolol - EP2359815

The patent EP2359815 was granted to Egis Gygyszergyr Nyilvnosan MKD Rszvnytrsasg on Jan 8, 2020. The application was originally filed on Sep 30, 2009 under application number EP11003486A. The patent is currently recorded with a legal status of "Revoked".

EP2359815

EGIS GYGYSZERGYR NYILVNOSAN MKD RSZVNYTRSASG
Application Number
EP11003486A
Filing Date
Sep 30, 2009
Status
Revoked
Aug 22, 2024
Grant Date
Jan 8, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

KRKAOct 8, 2020HOEFER & PARTNER PATENTANWALTE MBBADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONDE20116428U
DESCRIPTIONUS6518288
DESCRIPTIONWO2005099699
OPPOSITIONDE20116428U
OPPOSITIONEP1309317
OPPOSITIONEP2344141
OPPOSITIONIN224215
OPPOSITIONWO03032954
OPPOSITIONWO2005099699
SEARCHDE20116428U
SEARCHEP0902016
SEARCHGB2444904
SEARCHIN224215
SEARCHWO2005099699

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "Amlodipine Besilate", Anonymous, BRITISH PHARMACOPOEIA, (20050000), vol. I, pages 126 - 128, XP055682002-
OPPOSITION- Anonymous, "Annex 9 Guidelines on packaging for pharmaceutical products", WHO Technical Report Series no. 902, (20020000), pages 119 - 156, XP055681898-
OPPOSITION- "Bisoprolol Fumarate", Anonymous, USP-NF, (20060000), pages 292 - 295, XP055682005-
OPPOSITION- Brian A Carlin, "5 Direct Compression and the Role of Filler-binders", Brian A Carlin, Larry L Augsburger, Stephen W. Hoag, Pharmaceutical Dosage Forms: Tablets, Third Edition, volume 2 - Rational Design and Formulation, CRC Press, (20080000), pages 173 - 183, 212-216, XP055682158-
OPPOSITION- Rana R; Patil A, "Efficacy and Safety of Bisoprolol plus Amlodipine Fixed Dose Combination in Essential Hypertonia", The Indian Practitioner, (20080400), vol. 61, no. 4, pages 225 - 234, XP055681901-
OPPOSITION- Raymond C Rowe, HANDBOOK OF PHARMACEUTICAL EXCIPIENTS, Fifth Edition, Pharmaceutical Press, (20060000), page 3pp-
OPPOSITION- Raymond C Rowe; Paul J Sheskey; Sian C Owen, Handbook of pharmaceutical excipients. Fifth edition, Pharmaceutical Press, London, (20060000), pages 418 - 421, XP055681947-
OPPOSITION- Rowe R C, HANDBOOK OF PHARMACEUTICAL EXCIPIENTS, Fifth Edition, Pharmaceutical Press, (20060000), pages 93 - 99, XP055674119-
OPPOSITION- Wolfgang A Ritschel; Annette Bauer-Brandl, Die Tablette Handbuch der Entwicklung, Herstellung und Qualitatssicherung, (20020000), pages 235 - 240, 252-265, XP055681939-
OPPOSITION- Wolfgang Jasek, Austria-Codex Fachinformation 2007/2008, WIEN, ÖSTERREICHISCHE APOTHEKER-VERLAGSGESELLSCHAFT M.B.H., (20070000), pages 1138-1139 , 392-417, 1200- 1207, 1992 - 1995 , 2690-2693, 5864 - 5869, XP055747887-
OPPOSITION- Akala O Emmanuel, "7.3 EFFECT OF PACKAGING ON STABILITY OF DRUGS AND DRUG PRODUCTS", Akala O Emmanuel, Shayne Cox Gad, Pharmaceutical Manufacturing Handbook: Regulations and quality, Wiley, (20080000), pages 641 - 686, XP055210404
OPPOSITION- Goyal; Tyagi R N; Bachheti A; Bishnoi N; S, "Voltammetric determination of bisoprolol fumarate in pharmaceutical formulations and urine using single-wall carbon nanotubes modified glassy carbon electrode", Electrochimica Acta, (20080000), vol. 53, no. 6, pages 2802 - 2808, XP022411215
OPPOSITION- Wendy A. DULIN, "Degradation of bisoprolol fumarate in tablets formulated with dicalcium phosphate", Drug Development and Industrial Pharmacy, (19950000), vol. 21, no. 4, pages 393 - 409, XP055747920
OPPOSITION- Vora D N; Kadav A A, "Development and Validation of a Simultaneous HPLC Method for Estimation of Bisoprolol Fumarate and Amlodipine Besylate from Tablets", Indian Journal of Pharmaceutical Sciences, (20080000), vol. 70, no. 4, pages 542 - 546, XP055681915
SEARCH- BURGES R A ET AL, "PHARMACOLOGIC PROFILE OF AMLODIPINE", AMERICAN JOURNAL OF CARDIOLOGY, CAHNERS PUBLISHING CO., NEWTON, MA, US LNKD- DOI:10.1016/0002-9149(89)90956-9, (19891107), vol. 64, no. 17, ISSN 0002-9149, pages 10I - 20I, XP000946560 [A] 1-12 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents